Adage Capital Partners GP »

Avalo Therapeutics Ord shares owned by Adage Capital Partners GP

Quarter-by-quarter ownership of Avalo Therapeutics Ord (AVTX) shares owned by Adage Capital Partners GP from 13F filings

Historical chart of Adage Capital Partners GP investment in Avalo Therapeutics Ord

Tip: Access up to 7 years of quarterly data

All positions including Avalo Therapeutics Ord held by Adage Capital Partners GP consolidated in one spreadsheet with up to 7 years of data

Download as csvDownload consolidated filings csv Download as ExcelDownload consolidated filings xlsx

Quarterly reported holdings in Avalo Therapeutics Ord by Adage Capital Partners GP

Quarter filed Position value Share count Share price at filing
2025-09-30 $3.3M 259k 12.71

More positions owned by Adage Capital Partners GP

NVIDIA Corporation (NVDA)
Microsoft Corporation (MSFT)
Apple (AAPL)
Amazon (AMZN)
Meta Platforms Cl A (META)
Broadcom (AVGO)
Alphabet Cap Stk Cl A (GOOGL)
Tesla Motors (TSLA)
Alphabet Cap Stk Cl C (GOOG)
Berkshire Hathaway Inc Del Cl B New (BRK.B)
JPMorgan Chase & Co. (JPM)
Eli Lilly & Co. (LLY)
Procter & Gamble Company (PG)
ConocoPhillips (COP)
Visa Com Cl A (V)

View all positions for Adage Capital Partners GP

Top funds holding Avalo Therapeutics Ord

BVF
OrbiMed Advisors
Nantahala Capital Management
Point72 Asset Management
Affinity Asset Advisors
Caligan Partners
Balyasny Asset Management
Silverarc Capital Management
Vanguard Group
RA Capital Management
Citadel Advisors
TCG Crossover Management
Commodore Capital
Velan Capital Investment Management
Adage Capital Partners GP

View all funds holding Avalo Therapeutics Ord